Latest News and Decisions

10 January 2019

At the meeting of 12 December 2018 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
iliotibial band syndrome 3/2019 4/2019
human immunodeficiency virus infection 5/2019 6/2019
internal derangement of the knee 7/2019 8/2019
Dupuytren disease 9/2019 10/2019
hypopituitarism 11/2019 12/2019
chondromalacia patella 1/2019 2/2019

These SOPs revoke the SOPs previously determined for these conditions.

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
sarcoidosis 13/2019 14/2019
localised sclerosis 15/2019 16/2019

The above SOPs take effect from 28 January 2019. The SOPs concerning localised sclerosis take effect from 23 July 2018.

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
gout Intention to remove one or more factors April 2019
dislocation Intention to remove one or more factors April 2019
joint instability Intention to remove one or more factors April 2019

Completed Investigations

The above determinations conclude the previously advertised investigations into:

Note:

The investigation concerning 'Dupuytren's disease' has resulted in the determination of Statements of Principles concerning Dupuytren disease.
The investigation concerning 'human immunodeficiency virus' has resulted in the determination of Statements of Principles concerning human immunodeficiency virus infection.
The Amendment Statements of Principles concerning localised sclerosis correct a typographical error identified in the Statements of Principles concerning localised sclerosis (Nos. 61 & 62 of 2018). These Amendment Statements of Principles will have the same commencement date as the Statements of Principles concerning localised sclerosis (Nos. 61 & 62 of 2018). 

New Investigations

Decided to advertise the following investigations:

The above investigation notices appear in the Government Notices Gazette of 8 January 2019.